BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32555444)

  • 41. Short Chain Fatty Acids Enhance Aryl Hydrocarbon (Ah) Responsiveness in Mouse Colonocytes and Caco-2 Human Colon Cancer Cells.
    Jin UH; Cheng Y; Park H; Davidson LA; Callaway ES; Chapkin RS; Jayaraman A; Asante A; Allred C; Weaver EA; Safe S
    Sci Rep; 2017 Aug; 7(1):10163. PubMed ID: 28860561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-chain fatty acids and trichostatin A alter tight junction permeability in human umbilical vein endothelial cells.
    Miyoshi M; Usami M; Ohata A
    Nutrition; 2008; 24(11-12):1189-98. PubMed ID: 18723323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy.
    Feng Y; Wang Y; Wang P; Huang Y; Wang F
    Cell Physiol Biochem; 2018; 49(1):190-205. PubMed ID: 30138914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model.
    Ellis K; Marlin JW; Taylor TA; Fitting S; Hauser KF; Rice G; McRae M
    J Pharm Pharmacol; 2015 Feb; 67(2):178-88. PubMed ID: 25557407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region.
    Kalina U; Koyama N; Hosoda T; Nuernberger H; Sato K; Hoelzer D; Herweck F; Manigold T; Singer MV; Rossol S; Böcker U
    Eur J Immunol; 2002 Sep; 32(9):2635-43. PubMed ID: 12207348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A; Sabit H; Amidon GL
    AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of short-chain fatty acids butyrate, propionate, and acetate on urothelial cell kinetics in vitro: potential therapy in augmentation cystoplasty.
    Dyer JP; Featherstone JM; Solomon LZ; Crook TJ; Cooper AJ; Malone PS
    Pediatr Surg Int; 2005 Jul; 21(7):521-6. PubMed ID: 15864601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines.
    Yano K; Okabe C; Fujii K; Kato Y; Ogihara T
    J Pharm Pharmacol; 2020 Apr; 72(4):575-582. PubMed ID: 31975441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Butyrate from pectin fermentation inhibits intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E-deficient mice.
    Chen Y; Xu C; Huang R; Song J; Li D; Xia M
    J Nutr Biochem; 2018 Jun; 56():175-182. PubMed ID: 29574331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-chain fatty acids inhibit the activation of T lymphocytes and myeloid cells and induce innate immune tolerance.
    Porbahaie M; Hummel A; Saouadogo H; Coelho RML; Savelkoul HFJ; Teodorowicz M; van Neerven RJJ
    Benef Microbes; 2023 Sep; 14(4):401-419. PubMed ID: 38661366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line.
    Zrieki A; Farinotti R; Buyse M
    Pharm Res; 2008 Sep; 25(9):1991-2001. PubMed ID: 18581209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2).
    Chen X; Unadkat JD; Mao Q
    Drug Metab Dispos; 2021 Oct; 49(10):910-918. PubMed ID: 34326138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin.
    Lehtisalo M; Keskitalo JE; Tornio A; Lapatto-Reiniluoto O; Deng F; Jaatinen T; Viinamäki J; Neuvonen M; Backman JT; Niemi M
    Clin Transl Sci; 2020 Nov; 13(6):1236-1243. PubMed ID: 32453913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies.
    Shimizu R; Matsuzaki T; Oka R; Sonoyama T; Fukuhara T; Kuwata A; Matsuo Y; Kubota R
    J Clin Pharmacol; 2023 Aug; 63(8):918-927. PubMed ID: 37043676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superior inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis: linking dietary fiber to cancer prevention.
    Zeng H; Hamlin SK; Safratowich BD; Cheng WH; Johnson LK
    Nutr Res; 2020 Nov; 83():63-72. PubMed ID: 33017771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.
    Han LW; Gao C; Mao Q
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function.
    Kleuskens MTA; Haasnoot ML; Herpers BM; Ampting MTJV; Bredenoord AJ; Garssen J; Redegeld FA; van Esch BCAM
    Allergy; 2022 May; 77(5):1510-1521. PubMed ID: 34458999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.